Devices, cartridges, and method are described herein for emulating smoking wherein a device generates an aerosol for inhalation by a subject by heating a viscous material that can have a tactile response in the mouth or respiratory tract, while reducing Hoffman analytes and mutagenic compounds delivered to the user as compared to a common tobacco cigarette.

The present invention relates to a cosmetic composition for dyeing keratin fibers, in particular human keratin fibers such as the hair, comprising: a) one or more fatty substances; b) one or more surfactants; c) one or more oxidation bases; d) one or more couplers based on 2-hydroxynaphthalene derivatives or particular phenol derivatives, acylaminophenol derivatives or quinoline derivatives; f) one or more basifying agents; e) optionally one or more chemical oxidizing agents; and the fatty substance content representing in total at least 25% by weight relative to the total weight of the formulation. The present invention also relates to a process using this composition, and to a multi-compartment device that is suitable for performing the said process.

The invention relates to a device for evaporating volatile substances, comprising a heat source (5) evaporating volatile substances from a refill (2), a heat detector (4) which can detect the heat from said heat source (5), and indicating means (7) connected to said heat detector (4) emitting an indication when the heat detector (4) detects the heat from said heat source (5), and characterized in that said heat detector (4) is placed above said heat source (5). The invention allows the indicating means to be activated virtually in a simultaneous manner with the placement of the heat emitter.

A nozzle device for dispensing flowable substances, having a support and a nozzle element arranged at least in part within this support, which element is suitable and intended for dispensing the flowable substance, and having a first coupler, in order to arrange the nozzle device detachably to a supply for the flowable substance. According to the invention, the nozzle device has a second coupler in order to fasten the nozzle device detachably to a further nozzle device.

Device for evaporating volatile substances including a container for a liquid that contains volatile substances and means for evaporating the volatile substances, where the means for evaporating the volatile substances include two semipermeable membranes, such that the device allows the optimisation of the evaporation of the volatile substances present in the liquid, doubling the evaporation surface thereof compared to conventional devices, and increases the user's perception of the amount of liquid evaporated.

A system and method for creating a medicated atmosphere in an organ, or body cavity is disclosed. The system includes a flexible nebulization catheter that can be manipulated during use, a device for the introduction of the nebulization catheter, a medication delivery apparatus configured to control delivery of a medication to the catheter, a gas delivery apparatus in communication with the catheter, a gas pressure relief apparatus configured to relieve pressure in the organ or body cavity, and a central controller. The system may include a liquid source having a mixture of hyaluronic acid and heparin that, in conjunction with the nebulizing catheter, are designed to generate an aerosol with a particle size of 10-25 microns in a body cavity. The method includes providing an aerosol of anti-adhesive medication to an organ or body cavity while controlling overall pressure in the organ or cavity.

The Drug and Alcohol Office is touring regional Western Australia in an effort to improve substance abuse prevention, treatment and support.

Joshua Glenn is banned from competitive football for four years by the Australian Sports Anti-Doping Authority after testing positive to a prohibited substance.

A 22-year-old Queensland man dies after attending the Lost Paradise music festival on the NSW Central Coast as police reveal the sophisticated and bizarre ways revellers attempt to smuggle drugs in including inside a barbecue chicken.

“I should be dead.”

MAP Health Management and IBM Watson Health today announced a partnership that aims to address the pervasive problem of relapse among Americans suffering from Substance Use Disorder, a chronic disease. MAP will integrate Watson cognitive technologies into the MAP Recovery Network Platform to enhance the platform’s existing capabilities around patient risk models. In doing so, it is anticipated that behavioral health and substance abuse treatment providers that use the MAP platform will be better able to predict and prevent incidence of relapse nationwide.

read more

Angels have fired longtime visiting clubhouse attendant Brian "Bubba" Harkins for allegedly providing illegal substances to put on baseballs

Consider these scenarios. Scandal A: A prominent politician gets caught sleeping with a campaign aide and plunges himself into an ugly paternity dispute -- all while his cancer-stricken wife is fighting for her life.

North Dakota lawmakers fended off an effort to ensure that the state's new standards, and any tests that might be used with them, won't mirror the common core.

Paris : J.-B. Baillière, 1876.

Edinburgh : Bell & Bradfute, 1813.

London : Longmans, Green, 1902.

Paris : Masson, 1870.

Rockville, Maryland : National Institute on Drug Abuse, [1983]

Rockville, Maryland : National Institute on Drug Abuse, 1988.

Rockville, Maryland : National Institute on Drug Abuse, 1980.

Conduct problems, substance use, substance use problems, and depressive symptoms increase as black adolescents enter high school. Although family-centered prevention programs deter these problems during middle school, no such programs have been developed and evaluated for black high school students.

This study demonstrates that participation in a family-centered preventive intervention reduces conduct problems, substance use, and substance use problems among black adolescents by more than 30% compared with adolescents in an attention control condition across nearly 2 years. (Read the full article)

Primary care settings provide an important venue for early detection of substance use and intervention, but adolescent screening rates need improvement. Screening and brief interventions appear effective in reducing adult problem drinking but evidence for effectiveness among adolescents is needed.

A computer-facilitated system for screening, feedback, and provider brief advice for primary care can increase adolescent receipt of substance use screening across a variety of practice settings, and shows promise for reducing adolescents’ use of alcohol and cannabis. (Read the full article)

Research demonstrates that substance use, beliefs about use, and influence from family and friends can put young adults at risk for DUI and RWDD. Much of this research is cross-sectional and focuses on risk factors identified in young adults.

This longitudinal study emphasizes the importance of prevention efforts in early adolescence at multiple levels to reduce high school DUI/RWDD, because marijuana beliefs and marijuana use by peers and family members during middle school were associated with high school DUI/RWDD. (Read the full article)

Secretary of State Jeffrey Bullock has suspended the Delaware medical license and controlled substance privileges of Gregory Villabona, in light of allegations of unprofessional conduct related to the prescription and distribution of opioid medications.

Secretary of State Jeffrey Bullock has suspended the Delaware medical license and controlled substance prescribing privileges of Ifeanyi Udezulu for repeatedly failing to adhere to state regulations for the safe prescribing of opioid medications.

NEW CASTLE (July 24, 2018) – Following a 14-month review of Delaware’s opioid use disorder treatment system, a research team from the Johns Hopkins Bloomberg School of Public Health and the Bloomberg American Health Initiative today recommended four major strategies to achieve the state’s goal of a system of care that is accessible, evidence-based, individualized, […]

NEW CASTLE (Oct. 2, 2018) – The Department of Health and Social Services’ Division of Substance Abuse and Mental Health (DSAMH) last week launched its online referral network – Delaware Treatment and Referral Network (DTRN) – allowing Delaware health care providers seeking substance use disorder treatment or mental health services for their patients to make […]

WILMINGTON (Oct. 3, 2018) – As a way to engage more Delawareans suffering from substance use disorder in treatment, while also meeting their accompanying needs for housing, employment, education and other wraparound services, the Department of Health and Social Services (DHSS) today launched its START Initiative with a press conference and a daylong forum for […]

NEW CASTLE (March 26, 2019) – As a new support for individuals and families impacted by the effects of mental health and substance use disorders, the Division of Substance Abuse and Mental Health (DSAMH) and its partners have opened the Bridge Clinic near New Castle to provide screening and referrals to treatment, as well as […]

DOVER (May 9, 2019) – On May 8, 2019, the medical license and controlled substance registrations of Nihar B. Gala, MD, were permanently revoked by the Delaware Board of Medical Licensure and Discipline. The revocation was a result of allegations of unprofessional conduct related to the prescription of opioids to a patient at high risk […]

DOVER (Aug. 1, 2019) – On July 30, 2019, the medical license and controlled substance registration of Damon Cary, MD, were suspended temporarily by the Delaware Board of Medical Licensure and Discipline. The suspension was the result of a request made by the Delaware Attorney General’s Office following investigations into the prescribing and treatment practices […]

DHSS Secretary Dr. Kara Odom Walker says, “In the midst of the opioid crisis we are facing in Delaware and across the country, (these facilities) are another resource we can use to better serve our Medicaid clients in need of treatment for substance use disorder.” NEW CASTLE (Aug. 5, 2019) – The Department of Health […]

By Kelly Scanlon, director, environment, health and safety policy and research, IPC The U.S. Environmental Protection Agency (EPA) released “scoping documents” for its upcoming reviews of certain high-priority chemical substances under the Toxic Substances Control Act (TSCA) Section 6(b). Your review of these documents is important because scoping is the foundation of the risk evaluation […]

Do you import or otherwise place products on the EEA market? If so, you should be aware of the new European Chemicals Agency (“ECHA”) SCIP database. Companies placing products (articles) on the EEA market, including companies importing s...

Title: Scientists Discover Substance That Causes Pain
Category: Health News
Created: 4/28/2010 2:10:00 PM
Last Editorial Review: 4/29/2010 12:00:00 AM

Title: Teen Impulsiveness Has Different Sources in ADHD, Substance Use
Category: Health News
Created: 4/29/2012 4:05:00 PM
Last Editorial Review: 4/30/2012 12:00:00 AM

BACKGROUND Pregnant patients from rural counties of Western North Carolina face additional barriers when accessing comprehensive perinatal substance use disorders care at Project CARA as compared to patients local to the program in Buncombe County. We hypothesized regional patients would be less engaged in care.

METHOD Using a retrospective cohort design, univariate analyses (², t-test; P < .05) compared patients' characteristics, engagement in care, and delivery outcomes. Engagement in care, the primary outcome, was operationalized as: attendance at expected, program-specific prenatal and postpartum visits, utilization of in-house counseling, community-based and/or inpatient substance use disorders treatment, and maternal urine drug screen at delivery negative for illicit substances.

RESULTS Regional patients (n = 324) were more likely than Buncombe County patients (n = 284) to have opioid [209 (64.5%) versus 162 (57.0%)] or amphetamine/methamphetamine use disorders (25 [7.7%] versus 13 [4.6%]), but less likely to have cannabis use (19 [5.9%] versus 38 [13.4%]; P = .009) and concurrent psychiatric disorders (214 [66.0%] versus 220 [77.5%]; P = .002). Engagement at postpartum visits was the significantly different outcome between patients (110/221 [49.8%] versus 146/226 [64.6%]; P = .002).

LIMITATIONS Outcomes were available for 66.8% of regional and 79.6% of Buncombe County patients of one program in one predominately white, non-Hispanic region of the state.

CONCLUSION Contrary to our hypothesis, regional and Buncombe County women engaged in prenatal care equally. However, a more formal transition into the postpartum period is needed, especially for regional women. A "hub-and-spokes" model that extends delivery of perinatal substance use disorders care into rural communities may be more effective for engagement retention.

A man was sprayed in the face with an "unknown substance" before a thief stole his bag on a London bus.

Disick's lawyers said he had checked into rehab to work on "past traumas" in relation to the death of his parents

Andrew Warren, 42, a former official with the Central Intelligence Agency (CIA), pleaded guilty today to a two-count criminal information charging him with abusive sexual contact and unlawful use of cocaine while possessing a firearm.

Senior U.S. District Judge Jack T. Camp Jr., pleaded guilty today in U.S. District Court in Atlanta to possession of controlled substances and conversion of government property.

Attorney General Eric Holder, Department of Health and Human Services Secretary Kathleen Sebelius and Department of the Interior Secretary Ken Salazar today announced a new federal framework to assist American Indian and Alaska Native communities in achieving their goals in the prevention, intervention and treatment of alcohol and substance abuse.

Dover Chemical Corporation has agreed to pay $1.4 million in civil penalties for the unauthorized manufacture of chemical substances at facilities in Dover, Ohio, and Hammond, Ind.

The United States has filed suit against PharMerica Corp. in the U.S. District Court for the Eastern District of Wisconsin. The lawsuit alleges that PharMerica violated the False Claims Act and the Controlled Substances Act by dispensing controlled drugs without valid prescriptions and causing claims for illegally dispensed drugs to be submitted to the Medicare program.